Linked Life Data

20533893

Source:http://linkedlifedata.com/resource/pubmed/id/20533893

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2010-7-23
pubmed:abstractText
Increasing clinical evidences suggest that melatonin receptor agonists can represent a novel therapeutic approach for the treatment of sleep disturbances and depression. A variety of studies also revealed a role of melatonin and its receptors in different patho-physiological conditions. Due to the multiple effects of this hormone, the design of new agents able to interact selectively with melatonin receptors has become an area of great interest during the last decade.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1744-7674
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1059-77
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.
pubmed:affiliation
Dipartimento Farmaceutico, Università degli Studi di Parma, Italy. marco.mor@unipr.it
pubmed:publicationType
Journal Article, Review